Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target-Reference-Cited by-同舟云学术

Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target

Published:2007-06-19 Issue:6 Volume:4 Page:e206
ISSN:1549-1676
Container-title:PLoS Medicine
language:en
Short-container-title:PLoS Med

Author:

Kuntz Angela N,Davioud-Charvet Elisabeth,Sayed Ahmed A,Califf Lindsay L,Dessolin Jean,Arnér Elias S. J,Williams David L

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference72 articles.

1. Reassessment of the cost of chronic helmintic infection: A meta-analysis of disability-related outcomes in endemic schistosomiasis.;Lancet,2005

2. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria: A comprehensive pro-poor health policy and strategy for the developing world.;PLoS Med,2006

3. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials.;Antimicrob Agents Chemother,2003

4. Drugs for the control of parasitic diseases: Current status and development in schistosomiasis.;Trends Parasitol,2003

5. Drug resistance in schistosomes.;Parasitol Today,1993

Cited by 314 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The “Doorstop Pocket” In Thioredoxin Reductases─An Unexpected Druggable Regulator of the Catalytic Machinery;Journal of Medicinal Chemistry;2024-09-09

2. Computational modeling and molecular dynamics studies of methyl sulfonyl acetate derivatives as potent SmTGR inhibitors: insights into binding interactions;Molecular Simulation;2024-09-05

3. Evaluating the thioredoxin reductase selenoprotein as potential drug target for treatment of Acanthamoeba infections;International Journal for Parasitology: Drugs and Drug Resistance;2024-09

4. Identification and characterization of archaeal-type FAD synthase as a novel tractable drug target from the parasitic protozoa Entamoeba histolytica;mSphere;2024-08-27

5. The Many Lives of Auranofin: How an Old Anti-Rheumatic Agent May Become a Promising Antimicrobial Drug;Antibiotics;2024-07-15